Sometimes plan members can struggle trying to find the right medication. This can be very challenging for them as they deal with the constant prescription changes and the accompanying side effects. But, there’s an innovation that can help.
Pharmacogenomics uses DNA to uncover which drugs might be better for each person, based on their unique genome. A simple saliva test can tell doctors which drugs will likely be more effective for each person and provide faster, better outcomes.
- A reduction in harmful side-effects from taking the wrong medication
- Patients feel better faster
- Patients can get back to work more quickly than with traditional trial and error treatment
You can now add pharmacogenomics to your EHC plan.
Sun Life doesn’t limit the conditions for which pharmacogenomic testing can be prescribed. There’s rapid innovation in this space and as more conditions are included, it means better support for plan sponsors. A doctor may choose to work with any lab they feel is appropriate based on a plan member’s specific health needs.
It’s also part of our Disability Management Toolkit
We use pharmacogenomics as part of our disability management toolkit for mental health and chronic pain claims*. Our goal is to have plan members feeling better, faster. This supports a sustained and productive return to work.
From pilot to launch: closing the gaps around access to mental health care.
This Bright Paper report outlines how pharmacogenomics and other innovations can improve mental health outcomes.
* Claims must meet defined criteria.